HCPCS J7999: Compounded Drug, Not Otherwise Classified
HCPCS Level II code J7999 represents a catch-all classification for compounded drugs not otherwise classified. It matters nationally because compounded pharmaceuticals are commonly used when commercially available products do not meet a patient’s clinical needs, and reimbursement pathways for these items can vary across major payers. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn what J7999 covers, typical sites of service where compounded drugs are provided, and the clinical context for using compounded preparations. The publication also summarizes payer coverage patterns and common billing considerations, clarifies where data is not available in the input, and highlights coding contexts that affect reimbursement and claims adjudication. This summary provides a national perspective useful for billing staff, revenue cycle managers, and clinical teams who handle compounded pharmaceuticals in outpatient and ambulatory settings.
Customize your policy alerts
Sign up for hcpcs J7999 policy alerts
Get alerted when payer policies referencing J7999 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code J7999 denotes a compounded drug, not otherwise classified. This code is used to report compounded medications that do not have a specific HCPCS Level II code assigned. The service type associated with this code is administration or provision of a compounded pharmaceutical product. The typical site of service for items billed with this code includes outpatient infusion centers, physician offices, hospital outpatient departments, and other ambulatory care settings where compounded medications are furnished to patients.